This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Sodium Chloride Injection USP (2016-05-10)

Starting date:
May 10, 2016
Posting date:
May 31, 2016
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-58662

Affected products

Sodium Chloride Injection USP

Reason

Out of specification result for pH during stability testing.

Depth of distribution

Retailers across Canada

Affected products

Sodium Chloride Injection USP

DIN, NPN, DIN-HIM
Din 02150204
Dosage form

Solution

Strength

9 mg/mL Sodium chloride

Lot or serial number

5B898

Companies
Recalling Firm
Omega Laboratories Ltd.
11177 Hamon
Montreal
H3M 3E4
Quebec
CANADA
Marketing Authorization Holder
Omega Laboratories Ltd.
11177 Hamon
Montreal
H3M 3E4
Quebec
CANADA

Date modified: